Barclays Maintains Equal-Weight on Adient, Raises Price Target to $29

Benzinga Newsdesk www.benzinga.com Positive 70.8%

Neg 0% Neu 0% Pos 70.8%

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and raises the price target from $26 to $29.

Comments

No comments yet. Be the first!